GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.01, with a volume of 15,603 shares traded.
GB Sciences Price Performance
GB Sciences Company Profile
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Read More
- Five stocks we like better than GB Sciences
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Are Penny Stocks a Good Fit for Your Portfolio?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What Investors Need to Know to Beat the Market
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
